Category: Manufacturing, Packaging & Detailing
Global Manufacturing, Packaging & Detailing
-
Sanitary Valves
... CAGR of 3.4% over the analysis period 2024-2030. Control Valves, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$223.4 Million by the end of the analysis ... Read More
-
Pharmaceutical Glass Packaging
... at a CAGR of 7.6% over the analysis period 2024-2030. Bottles, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$10.5 Billion by the end of the ... Read More
-
Ginseng
... 10.2% over the analysis period 2024-2030. Asian Ginseng, one of the segments analyzed in the report, is expected to record a 10.0% CAGR and reach US$11.2 Billion by the end of the analysis period. Growth ... Read More
-
Contract Packaging
... CAGR of 8.7% over the analysis period 2024-2030. Food & Beverage, one of the segments analyzed in the report, is expected to record a 8.7% CAGR and reach US$55.4 Billion by the end of the ... Read More
-
Bulk Paclitaxel
... CAGR of 8.5% over the analysis period 2024-2030. Semi-Synthetic Paclitaxel API, one of the segments analyzed in the report, is expected to record a 8.8% CAGR and reach US$139.1 Million by the end of the ... Read More
-
Human Growth Hormone Drugs
... 2030, growing at a CAGR of 4.2% over the analysis period 2024-2030. Subcutaneous, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$3.4 Billion by the end ... Read More
-
Antibacterial Drugs
... CAGR of 3.8% over the analysis period 2024-2030. ß-lactams, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach US$35.4 Billion by the end of the analysis period. ... Read More
-
Global N-Acetyl-L-Cysteine Market Research Report 2025
... N-Acetyl-L-Cysteine was increase from $ 65.64 million in 2024 to reach $ 107.24 million by 2031, at a CAGR of 7.87% during the forecast period of 2025 through 2031. China market for N-Acetyl-L-Cysteine was increase ... Read More
-
Global L-Creatine Market Research Report 2025
... L-Creatine was increase from $ 237.38 million in 2024 to reach $289.67 million by 2031, at a CAGR of 2.36% during the forecast period of 2025 through 2031. China market for L-Creatine is estimated to ... Read More
-
Global Seamless Capsule Market Report, History and Forecast 2020-2031
... report aims to provide a comprehensive presentation of the global market for Seamless Capsule, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in ... Read More
-
Healthcare Distribution
... CAGR of 13.5% over the analysis period 2024-2030. Pharmaceutical, one of the segments analyzed in the report, is expected to record a 13.3% CAGR and reach US$2.3 Trillion by the end of the analysis period. ... Read More
-
Attapulgite
... 6.9% over the analysis period 2024-2030. Colloidal grade, one of the segments analyzed in the report, is expected to record a 8.5% CAGR and reach US$320.0 Million by the end of the analysis period. Growth ... Read More
-
Superdisintegrants
... 5.4% over the analysis period 2024-2030. Synthetic Superdisintegrants, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$262.2 Million by the end of the analysis period. Growth ... Read More
-
Sterols
... 5.8% over the analysis period 2024-2030. Vegetable oil, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$937.0 Million by the end of the analysis period. Growth ... Read More
-
Pharmaceutical Packaging Equipment
... at a CAGR of 8.6% over the analysis period 2024-2030. Primary Packaging Equipment, one of the segments analyzed in the report, is expected to record a 8.8% CAGR and reach US$16.7 Billion by the end ... Read More
-
Anti-Infectives
... 6.2% over the analysis period 2024-2030. Anti-Viral Drugs, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$117.1 Billion by the end of the analysis period. Growth ... Read More
-
Analgesics
... 5.3% over the analysis period 2024-2030. Prescription, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$43.8 Billion by the end of the analysis period. Growth in ... Read More
-
Semi-Automatic Filling Equipment
... at a CAGR of 6.6% over the analysis period 2024-2030. Food & Beverages, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$2.0 Billion by the end ... Read More
-
Tangential Flow Filtration
... at a CAGR of 12.0% over the analysis period 2024-2030. Single-Use Systems, one of the segments analyzed in the report, is expected to record a 13.3% CAGR and reach US$2.0 Billion by the end of ... Read More
-
Analytical Standards
... CAGR of 6.6% over the analysis period 2024-2030. Pharmaceutical & Life Science Analysis Application, one of the segments analyzed in the report, is expected to record a 7.4% CAGR and reach US$611.4 Million by the ... Read More
-
Contract Research Outsourcing
... at a CAGR of 7.9% over the analysis period 2024-2030. Clinical, one of the segments analyzed in the report, is expected to record a 8.2% CAGR and reach US$61.2 Billion by the end of the ... Read More
-
Ibuprofen API
... CAGR of 0.9% over the analysis period 2024-2030. Arthritis Application, one of the segments analyzed in the report, is expected to record a 1.4% CAGR and reach US$392.0 Million by the end of the analysis ... Read More
-
Glucosamine
... 6.9% over the analysis period 2024-2030. Nutritional Supplements, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$1.2 Billion by the end of the analysis period. Growth ... Read More
-
Anti-Counterfeit Packaging
... CAGR of 9.2% over the analysis period 2024-2030. Mass Encoding, one of the segments analyzed in the report, is expected to record a 9.6% CAGR and reach US$109.6 Billion by the end of the analysis ... Read More
-
Hormone Replacement Therapy (HRT)
... 2030, growing at a CAGR of 6.1% over the analysis period 2024-2030. Estrogen Hormone Replacement Therapy, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$24.2 Billion ... Read More
Research Assistance
